📰 Script Probio News
Page 2 - Script Probio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Script Probio. Real-time updates on events, politics, business and more.
June 15, 2022
LEIDEN, Netherlands, June 15, 2022 /PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing
June 15, 2022
LEIDEN, the Netherlands, June 15, 2022 / B3C newswire / -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing of its premium 2G UNic™ technology for boosting therapeutic protein production to GenScript ProBio, a global contract...
June 15, 2022
/PRNewswire/ -- ProteoNic BV, a leading provider of premium vector technology and services for efficient production of biologics, today announced licensing of...
June 13, 2022
Over the past ten years, Athenex has established a productive relationship with GenScript and GenScript ProBio as a provider of high-quality reagents and materials to support multiple Research and Development initiatives
May 12, 2022
/PRNewswire/ -- On the May 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO company from GenScript Biotech Corporation, today announced the...
December 8, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation.
December 8, 2021
Continued manufacturing expansion facilitates one-stop plasmid services for global customers in Europe and beyond GenScript ProBio announced today the opening of China's largest commercial GMP plasmid
December 7, 2021
/PRNewswire/ -- On December 7th, the "Opening Ceremony of GenScript ProBio Plasmid Commercial GMP Manufacturing facility and Open Day" was rounded off....
February 22, 2021
22 febbraio 2021 10:13 Fonte: Adnkronos #salute-e-benessere NANJING, China, Feb. 22, 2021 /PRNewswire/ -- On February 21, 2021, GenScript ProBio and SunRock Biopharma, a company focused on the development of antibody therapeutics targeting cancer, announced a collaboration spanning preclinical discovery to large scale GMP manufacturing for SunRocks CCR9 therapeutic antibody candidates. GenScript ProBio will provide SunRock Biopharma a one-stop-solution from antibody discovery, cell line develo...
February 22, 2021
(1) NANJING, China, Feb. 22, 2021 /PRNewswire/ -- On February 21, 2021, GenScript ProBio and SunRock Biopharma, a company focused on the development of antibody therapeutics targeting cancer, announced a collaboration spanning preclinical discovery to large scale GMP manufacturing for SunRocks CCR9 therapeutic antibody candidates. GenScript ProBio will provide SunRock Biopharma a one-stop-solution from antibody discovery, cell line development, process development to GMP drug substance and drug...